1. Hu, Xinyu, Wu, Jianfeng, Feng, Yong, Chen, Wei, He, Xia. . METTL3-stabilized super enhancers-lncRNA SUCLG2-AS1 mediates the formation of a long-range chromatin loop between enhancers and promoters of SOX2 in metastasis and radiosensitivity of nasopharyngeal carcinoma. In Clinical and translational medicine, 13, e1361. doi:10.1002/ctm2.1361. https://pubmed.ncbi.nlm.nih.gov/37658588/
2. Zhang, Xiaomin, Liu, Juan, Cheng, Yujie, Liu, Shuxun, Cao, Xuetao. 2023. Metabolic enzyme Suclg2 maintains tolerogenicity of regulatory dendritic cells diffDCs by suppressing Lactb succinylation. In Journal of autoimmunity, 138, 103048. doi:10.1016/j.jaut.2023.103048. https://pubmed.ncbi.nlm.nih.gov/37216870/
3. Zhang, Zheying, Zhu, Huifang, Li, Qian, Yang, Rui, Zhong, Jiateng. 2021. Gene Expression Profiling of Tricarboxylic Acid Cycle and One Carbon Metabolism Related Genes for Prognostic Risk Signature of Colon Carcinoma. In Frontiers in genetics, 12, 647152. doi:10.3389/fgene.2021.647152. https://pubmed.ncbi.nlm.nih.gov/34589110/
4. Lin, Shian-Ren, Wen, Yu-Ching, Yeh, Hsiu-Lien, Chen, Wei-Yu, Liu, Yen-Nien. 2020. EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer. In Oncogene, 39, 6757-6775. doi:10.1038/s41388-020-01468-9. https://pubmed.ncbi.nlm.nih.gov/32963351/
5. Ramirez, Alfredo, van der Flier, Wiesje M, Herold, Christine, Becker, Tim, Nöthen, Markus M. 2014. SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. In Human molecular genetics, 23, 6644-58. doi:10.1093/hmg/ddu372. https://pubmed.ncbi.nlm.nih.gov/25027320/
智鼠故事 
